webinar register page

Webinar banner
PCSS Exchange
NOTE: The start time should display in your local time zone, but occasionally it does not adjust correctly. The sessions begin at 3pm ET / 2pm CT / 12pm PT.

PCSS Exchange is a six-session online course focused on the implementation of prescribing medications for treating opioid use disorder (MOUD) in a variety of healthcare settings. The course content is built around the EPIS (Explore, Prepare, Implement, Sustain) Framework of implementation.

PCSS-X is intended for an interprofessional audience. The first three sessions are focused on broader issues of establishing an MOUD program. The final three sessions will focus on clinical considerations when prescribing MOUD and will increase waivered and waiver-eligible providers’ knowledge and confidence related to prescribing MOUD to a variety of patients. Prescribers with frontline experience prescribing MAT and developing clinic workflows will be available during all six sessions to answer participants’ questions and discuss real-world cases.

Target Audience
Sessions 1-3: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, social workers, clinical administrators and healthcare teams.
Sessions 4-6: Physicians, nurse practitioners or other advanced practice nurses, PAs, and healthcare teams.

Bios for the subject matter experts for Session #5 are at the bottom of this page. Detailed summaries and the list of SMEs for each session are available at https://pcssnow.org/education-training/pcss-exchange/.

Funding for this initiative was made possible (in part) by grant no. 6H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
You can choose to attend one or more of the following webinars.

Time shows in
* Required information


Gavin Bart, MD, PhD
Dr. Bart is Director of the Division of Addiction Medicine at Hennepin Healthcare and Professor of Medicine at the University of Minnesota. His areas of expertise include clinical pharmacology and the pharmacological management of opioid use disorders. His current research areas include the population pharmacokinetics of methadone, genetic influences of methadone pharmacology and treatment outcome, and implementation of opioid use disorder in hospital and primary care settings. He is PI of NorthStar Node of the NIDA National Drug Abuse Treatment Clinical Trials Network and has provided extensive international technical assistance to the PEPFAR/SAMHSA’s capacity building HIV and addiction efforts in Vietnam and South East Asia.
Annie Potter, MSN, MPH, NP, CARN-AP
Annie is a Clinical Educator with the Office Based Addiction Treatment Training and Technical Assistance + Program at Boston Medical Center and an Assistant Professor of Medicine at Boston University. Annie educates and supports health care providers on best practices in the treatment of substance use disorders. She is the Medical Director for the Massachusetts Office Based Addiction Treatment ECHO and is board certified in addictions and holds specialty certifications for treatment of HIV and Hepatitis C.
Andrew Saxon, MD
Dr. Saxon has more than a quarter century of experience as a clinical and research addiction psychiatrist. He is board certified with added qualifications in addiction psychiatry by the American Board of Psychiatry and Neurology. Dr. Saxon’s current research work is supported by the VA, NIDA, and NIMH and involves pharmacotherapies and psychotherapies for alcohol, tobacco, and opioid use disorders, work in co-occurrence of substance use disorders and PTSD, phenomenology and epidemiology of cannabis use, and treatment of substance use in primary care.